2023 Q4 Form 10-K Financial Statement

#000121390024057365 Filed on July 01, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2023
Revenue $0.00 $0.00 $10.69M
YoY Change -100.0% 162.25%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses -$441.2K $470.4K $833.9K
YoY Change -146.54% -29.21% -70.35%
Operating Profit -$470.4K -$833.9K
YoY Change -29.21% -70.35%
Interest Expense $1.596M $2.596M $10.69M
YoY Change -33.23% 103.62% 162.27%
% of Operating Profit
Other Income/Expense, Net $97.80K -$243.0K $660.0K
YoY Change -88.41% 258.78% -91.53%
Pretax Income $2.471M $1.883M $10.42M
YoY Change 8.08% 246.86% 15.05%
Income Tax
% Of Pretax Income
Net Earnings $2.471M $1.883M $10.42M
YoY Change 8.08% 246.86% 15.05%
Net Earnings / Revenue 97.5%
Basic Earnings Per Share
Diluted Earnings Per Share $0.11 $0.07 $0.34
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q3 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $259.0K $0.00
YoY Change -100.0% -74.2% -100.0%
Cash & Equivalents $259.0K
Short-Term Investments
Other Short-Term Assets $25.89K $43.38K $25.89K
YoY Change -86.65% -85.2% -86.65%
Inventory
Prepaid Expenses $25.89K
Receivables
Other Receivables
Total Short-Term Assets $250.9K $302.4K $250.9K
YoY Change -72.75% -76.69% -72.75%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $157.3M $155.3M $157.3M
YoY Change -45.1% -45.36% -45.1%
Other Assets
YoY Change
Total Long-Term Assets $157.3M $155.3M $157.3M
YoY Change -45.1% -45.36% -45.1%
TOTAL ASSETS
Total Short-Term Assets $250.9K $302.4K $250.9K
Total Long-Term Assets $157.3M $155.3M $157.3M
Total Assets $157.6M $155.6M $157.6M
YoY Change -45.19% -45.5% -45.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $173.0K $0.00
YoY Change 665.36% -100.0%
Accrued Expenses $810.00 $1.102M $810.00
YoY Change -99.93% 68.21% -99.93%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $154.2K $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $805.00 $1.429M $810.00
YoY Change -99.94% 104.95% -99.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $723.6K $10.61M $723.6K
YoY Change -93.02% -5.38% -93.02%
Total Long-Term Liabilities $723.6K $10.61M $723.6K
YoY Change -93.02% -5.38% -93.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $805.00 $1.429M $810.00
Total Long-Term Liabilities $723.6K $10.61M $723.6K
Total Liabilities $724.4K $12.04M $724.4K
YoY Change -93.78% 1.08% -93.78%
SHAREHOLDERS EQUITY
Retained Earnings -$699.3K
YoY Change -93.48%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$698.5K $143.5M $156.9M
YoY Change
Total Liabilities & Shareholders Equity $157.6M $155.6M $157.6M
YoY Change -45.19% -45.5% -45.19%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2023
OPERATING ACTIVITIES
Net Income $2.471M $1.883M $10.42M
YoY Change 8.08% 246.86% 15.05%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$815.1K -$322.9K -$1.558M
YoY Change 194.05% -16.97% 11.5%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$450.0K $140.4M $139.9M
YoY Change
Cash From Investing Activities -$450.0K $140.4M $139.9M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.006M -140.1M -$139.1M
YoY Change
NET CHANGE
Cash From Operating Activities -815.1K -322.9K -$1.558M
Cash From Investing Activities -450.0K 140.4M $139.9M
Cash From Financing Activities 1.006M -140.1M -$139.1M
Net Change In Cash -259.0K -47.86K -$726.9K
YoY Change -6.57% -87.69% -47.98%
FREE CASH FLOW
Cash From Operating Activities -$815.1K -$322.9K -$1.558M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-40677
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1581691
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
2021 Fillmore St., #2089
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94115
CY2023 dei City Area Code
CityAreaCode
+1 (929)
CY2023 dei Local Phone Number
LocalPhoneNumber
529-7125
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Entity Shell Company
EntityShellCompany
true
CY2023Q2 dei Entity Public Float
EntityPublicFloat
301922550 usd
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023 dei Entity Registrant Name
EntityRegistrantName
PLUM ACQUISITION CORP. III
CY2023 dei Auditor Firm
AuditorFirmId
688
CY2023 dei Auditor Name
AuditorName
Marcum llp
CY2023 dei Auditor Location
AuditorLocation
Houston, TX
CY2022Q4 us-gaap Cash
Cash
726869 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25885 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
193947 usd
CY2023Q4 aptm Extension Contribution Due From Related Parties
ExtensionContributionDueFromRelatedParties
225000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
250885 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
920816 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
157330245 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
286583051 usd
CY2023Q4 us-gaap Assets
Assets
157581130 usd
CY2022Q4 us-gaap Assets
Assets
287503867 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
38866 usd
CY2022Q4 aptm Accounts Payable Related Party
AccountsPayableRelatedParty
15377 usd
CY2023Q4 aptm Accrued Expenses And Other Current Liabilities Current
AccruedExpensesAndOtherCurrentLiabilitiesCurrent
805 usd
CY2022Q4 aptm Accrued Expenses And Other Current Liabilities Current
AccruedExpensesAndOtherCurrentLiabilitiesCurrent
1214321 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
805 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1268564 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
723550 usd
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
482367 usd
CY2022Q4 aptm Deferred Underwriting Fee Payable Non Current
DeferredUnderwritingFeePayableNonCurrent
9887500 usd
CY2023Q4 us-gaap Liabilities
Liabilities
724355 usd
CY2022Q4 us-gaap Liabilities
Liabilities
11638431 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-699263 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10718408 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-698470 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-10717615 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
157581130 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
287503867 usd
CY2023 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
833935 usd
CY2022 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2812916 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-833935 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-2812916 usd
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
654 usd
CY2023 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
10686002 usd
CY2022 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
4074730 usd
CY2023 aptm Deal Termination Income
DealTerminationIncome
-374975 usd
CY2023 aptm Fair Value Adjustment Of Convertible Promissory Note Related Party
FairValueAdjustmentOfConvertiblePromissoryNoteRelatedParty
-95941 usd
CY2023 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-241183 usd
CY2022 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
7793783 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
336175 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
10418629 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
9055597 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-15698482 usd
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
4074730 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
9055597 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-10717615 usd
CY2023 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
9551325 usd
CY2023 aptm Deemed Contribution For Extension Deposit From Related Party
DeemedContributionForExtensionDepositFromRelatedParty
225000 usd
CY2023 aptm Deemed Contribution For Forgiveness Of Accrued Expenses Related Partys
DeemedContributionForForgivenessOfAccruedExpensesRelatedPartys
125940 usd
CY2023 aptm Deemed Contribution For Forgiveness Of Sponsor Loans Related Partys
DeemedContributionForForgivenessOfSponsorLoansRelatedPartys
123500 usd
CY2023 aptm Deemed Contribution For Forgiveness Of Accounts Payable Related Partys
DeemedContributionForForgivenessOfAccountsPayableRelatedPartys
325194 usd
CY2023 aptm Proceeds Received In Excess Of Initial Fair Value Of Related Party Convertible Promissory Note
ProceedsReceivedInExcessOfInitialFairValueOfRelatedPartyConvertiblePromissoryNote
-1060559 usd
CY2023 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
11811002 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
10418629 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-698470 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
10418629 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
9055597 usd
CY2023 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
10686002 usd
CY2022 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
4074730 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
241183 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7793783 usd
CY2023 aptm Fair Value Adjustment Of Convertible Promissory Note Related Party
FairValueAdjustmentOfConvertiblePromissoryNoteRelatedParty
-95941 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
336175 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-168062 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-340290 usd
CY2023 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-38866 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-13600 usd
CY2023 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-15377 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-32896 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-1213516 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
1121806 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1558003 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1397316 usd
CY2023 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
900000 usd
CY2023 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
140838808 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
139938808 usd
CY2023 aptm Proceeds From Advance From Sponsor
ProceedsFromAdvanceFromSponsor
6000 usd
CY2023 aptm Repayments Of Advance From Sponsor
RepaymentsOfAdvanceFromSponsor
6000 usd
CY2023 aptm Proceeds From Promissory Note Related Party
ProceedsFromPromissoryNoteRelatedParty
451134 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1280000 usd
CY2023 us-gaap Repayments Of Mandatory Redeemable Capital Securities
RepaymentsOfMandatoryRedeemableCapitalSecurities
140838808 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-139107674 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-726869 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1397316 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
726869 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2124185 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
726869 usd
CY2023 aptm Excess Of Cash Received Over Fair Value Of Convertible Promissory Note Related Party
ExcessOfCashReceivedOverFairValueOfConvertiblePromissoryNoteRelatedParty
1060559 usd
CY2023 aptm Waiver Of Deferred Underwriting Commissions By Underwriter
WaiverOfDeferredUnderwritingCommissionsByUnderwriter
9551325 usd
CY2023 aptm Deemed Contribution For Forgiveness Of Accrued Expenses Related Party
DeemedContributionForForgivenessOfAccruedExpensesRelatedParty
125940 usd
CY2023 aptm Deemed Contribution For Forgiveness Of Sponsor Loans Related Party
DeemedContributionForForgivenessOfSponsorLoansRelatedParty
123500 usd
CY2023 aptm Deemed Contribution For Forgiveness Of Accounts Payable Related Party
DeemedContributionForForgivenessOfAccountsPayableRelatedParty
325194 usd
CY2023 aptm Accretion Of Class A Ordinary Shares To Redemption Amount
AccretionOfClassAOrdinarySharesToRedemptionAmount
11811002 usd
CY2022 aptm Accretion Of Class A Ordinary Shares To Redemption Amount
AccretionOfClassAOrdinarySharesToRedemptionAmount
4074730 usd
CY2023Q4 aptm Extension Contribution Due From Related Parties
ExtensionContributionDueFromRelatedParties
225000 usd
CY2023Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
3902648 shares
CY2023Q4 aptm Founder Shares Percentage
FounderSharesPercentage
0.70 pure
CY2023Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1
CY2023 us-gaap Sponsor Fees
SponsorFees
112500 usd
CY2023Q4 us-gaap Deposits Assets
DepositsAssets
112500 usd
CY2023Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
5000001 usd
CY2023 aptm Percentage Of Restricted From Redeeming Shares
PercentageOfRestrictedFromRedeemingShares
1 pure
CY2023 us-gaap Interest Expense Other
InterestExpenseOther
100000 usd
CY2023 us-gaap Payments For Fees
PaymentsForFees
374975 usd
CY2023Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
5000001 usd
CY2023Q4 us-gaap Share Price
SharePrice
10.41
CY2023 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
140838808 usd
CY2023Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
153169659 usd
CY2023Q4 aptm Monthly Payment Amount For Extension
MonthlyPaymentAmountForExtension
225000 usd
CY2023 aptm Public Share Remains Outstanding
PublicShareRemainsOutstanding
0.03
CY2023Q4 us-gaap Deposits
Deposits
225000 usd
CY2023Q3 aptm Percentage Of Equity Holders
PercentageOfEquityHolders
1 pure
CY2023Q4 aptm Working Capital Deficit
WorkingCapitalDeficit
250080 usd
CY2023Q3 aptm Working Capital Loans
WorkingCapitalLoans
1500000 usd
CY2023 aptm Working Capital Loans
WorkingCapitalLoans
0 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates. The initial valuation of the Public Warrants (as defined in Note 3) and Class A ordinary shares subject to redemption, the initial and the quarterly valuation of the Private Placement Warrants (as defined in Note 4), and the valuations for the convertible Note (as defined in Note 5) required management to exercise significant judgement in its estimates.</p>
CY2022Q4 us-gaap Cash
Cash
726869 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
157330245 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
286583051 usd
CY2021Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
16641377 usd
CY2021Q4 aptm Underwriting Fees
UnderwritingFees
5650000 usd
CY2021Q4 aptm Underwriting Fees Deferred
UnderwritingFeesDeferred
9887500 usd
CY2021Q4 aptm Other Offering Costs
OtherOfferingCosts
967198 usd
CY2023 aptm Offering Costs Recognised As A Reduction Of Temporary Equity
OfferingCostsRecognisedAsAReductionOfTemporaryEquity
14937225 usd
CY2023 aptm Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
540944 usd
CY2023Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
12059166 shares
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p>
CY2023 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 usd
CY2023Q4 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
2030860 shares
CY2023Q4 aptm Sponsor Shares
SponsorShares
1128992 shares
CY2023 us-gaap Other Expenses
OtherExpenses
660000 usd
CY2022 us-gaap Other Expenses
OtherExpenses
660000 usd
CY2023Q4 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
110000 usd
CY2023Q4 aptm Proceeds From Cash Withdrawal From Trust Account
ProceedsFromCashWithdrawalFromTrustAccount
275000 usd
CY2023Q4 aptm Proceeds From Cash Withdrawal From Trust Account
ProceedsFromCashWithdrawalFromTrustAccount
280000 usd
CY2023 us-gaap Fees Paid On Acceptances Resold
FeesPaidOnAcceptancesResold
18738 usd
CY2022 us-gaap Fees Paid On Acceptances Resold
FeesPaidOnAcceptancesResold
95865 usd
CY2022Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
15377 usd
CY2023Q4 aptm Deferred Underwriting Commissions
DeferredUnderwritingCommissions
336175 usd
CY2023 aptm Class Of Warrants Or Rights Issued During The Period Units
ClassOfWarrantsOrRightsIssuedDuringThePeriodUnits
9705000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-241183 usd
CY2022 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
7793783 usd
CY2023Q4 us-gaap Shares Issued
SharesIssued
20523404 shares
CY2023 us-gaap Common Stock Voting Rights
CommonStockVotingRights
90.6%
CY2023Q4 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
134059215 usd
CY2023Q4 us-gaap Cash
Cash
usd
CY2022Q4 aptm Extension Contribution Due From Related Parties
ExtensionContributionDueFromRelatedParties
usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2023Q4 aptm Accounts Payable Related Party
AccountsPayableRelatedParty
usd
CY2023Q4 aptm Deferred Underwriting Fee Payable Non Current
DeferredUnderwritingFeePayableNonCurrent
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
CY2022 aptm Deal Termination Income
DealTerminationIncome
usd
CY2022 aptm Fair Value Adjustment Of Convertible Promissory Note Related Party
FairValueAdjustmentOfConvertiblePromissoryNoteRelatedParty
usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022 aptm Fair Value Adjustment Of Convertible Promissory Note Related Party
FairValueAdjustmentOfConvertiblePromissoryNoteRelatedParty
usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
usd
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022 aptm Proceeds From Advance From Sponsor
ProceedsFromAdvanceFromSponsor
usd
CY2022 aptm Repayments Of Advance From Sponsor
RepaymentsOfAdvanceFromSponsor
usd
CY2022 aptm Proceeds From Promissory Note Related Party
ProceedsFromPromissoryNoteRelatedParty
usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2022 us-gaap Repayments Of Mandatory Redeemable Capital Securities
RepaymentsOfMandatoryRedeemableCapitalSecurities
usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2022 aptm Excess Of Cash Received Over Fair Value Of Convertible Promissory Note Related Party
ExcessOfCashReceivedOverFairValueOfConvertiblePromissoryNoteRelatedParty
usd
CY2022 aptm Waiver Of Deferred Underwriting Commissions By Underwriter
WaiverOfDeferredUnderwritingCommissionsByUnderwriter
usd
CY2022 aptm Deemed Contribution For Forgiveness Of Accrued Expenses Related Party
DeemedContributionForForgivenessOfAccruedExpensesRelatedParty
usd
CY2022 aptm Deemed Contribution For Forgiveness Of Sponsor Loans Related Party
DeemedContributionForForgivenessOfSponsorLoansRelatedParty
usd
CY2022 aptm Deemed Contribution For Forgiveness Of Accounts Payable Related Party
DeemedContributionForForgivenessOfAccountsPayableRelatedParty
usd
CY2022Q4 aptm Extension Contribution Due From Related Parties
ExtensionContributionDueFromRelatedParties
usd
CY2023Q4 us-gaap Cash
Cash
usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
usd
CY2023Q4 us-gaap Cash
Cash
usd
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
usd
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
usd
CY2023Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
usd
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001845550

Files In Submission

Name View Source Status
0001213900-24-057365-index-headers.html Edgar Link pending
0001213900-24-057365-index.html Edgar Link pending
0001213900-24-057365.txt Edgar Link pending
0001213900-24-057365-xbrl.zip Edgar Link pending
aptm-20231231.xsd Edgar Link pending
ea0206794-10k_plumacq3.htm Edgar Link pending
ea020679401ex31-1_plumacq3.htm Edgar Link pending
ea020679401ex31-2_plumacq3.htm Edgar Link pending
ea020679401ex32-1_plumacq3.htm Edgar Link pending
ea020679401ex32-2_plumacq3.htm Edgar Link pending
ea020679401ex97-1_plumacq3.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
aptm-20231231_cal.xml Edgar Link unprocessable
aptm-20231231_def.xml Edgar Link unprocessable
aptm-20231231_lab.xml Edgar Link unprocessable
aptm-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ea0206794-10k_plumacq3_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending